Swingeing staff cuts at LION as firm restructures
LION bioscience has said it plans to cut its headcount by at least 50 per cent as part of a new restructuring drive, with most cuts being felt at the company's facilities in Heidelberg, Germany.
LION bioscience has said it plans to cut its headcount by at least 50 per cent as part of a new restructuring drive, with most cuts being felt at the company's facilities in Heidelberg, Germany.
Italian firm Chemi is moving production of the nutraceutical ingredient phosphatidylserine to its pharmaceutical actives plant in Brazil, allowing it to increase capacity and become more competitive on price.
Nanotechnology for molecular targeting and drug delivery is set to become a trillion-dollar industry with the drug sector's economic and technological leadership key to the growth of the technology.
In-Pharmatechnologist.com's periodic round-up of manufacturing developments from around the world sees Fujisawa expanding in Ireland, Solvay partnering in Russia, Vietnam's machinery firms undercutting competitors and a US plant purchase.
FMC BioPolymer is making progress in its collaboration with BioProgress and Harro Hoefliger on a machine to produce its recently-acquired NROBE tablet coating technology.
A new system that offers both pressure loss measurement and packaging seal strength has been launched.
The top two pharmaceutical companies have signaled their commitment to the adoption of radiofrequency identification (RFID) and electronic product code (EPC) technologies in the battle against counterfeit drugs.
German, US and Canadian researchers have discovered a gene and six mutations that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders.
The ingredients division of Danish company Chr Hansen pulled in a DKK 369 million (€49m) profit for the fiscal year on sales of DKK 3.4 billion (€460m), a slight dip on the previous year on rising costs.
Caliper Life Sciences has launched a new automated electrophoresis system that offers researchers a viable alternative to slab gel electrophoresis on a small microfluidic chip that is set to greatly increase sample throughput leading to a more...
US drug company VIVUS as been granted a US patent relating to a new drug delivery technology that makes it possible to spray drugs onto the skin and have them taken up into the blood.